Furthermore, in both AML cell lines and patient samples, transduction with PU.1 leads to increased apoptosis, and artificially increasing the PU.1 levels in these cells influences them towards myelomonocytic immunophenotype, differentiation into macrophages, and decreased proliferation correlated with diminished S-phase cell cycle kinetics (61). Here, SPI1 is linked to acute myeloid leukemia.